Restricting drug company access to doctors at academic medical centers resulted in a substantial reduction in the number of prescriptions that the physicians wrote for drugs touted by the pharmaceutical industry, a new study found.

The University of Pittsburgh School of Medicine was among 19 academic medical centers in five states that were examined in the study, which appeared in the latest issue of the Journal of the American Medical Association. The institutions represented nearly 35 percent of all prescriptions written in 2015.

The study is the latest to challenge direct pharmaceutical sales calls to doctors — a practice called detailing, which sometimes includes gifts and meals — to encourage the use of products that are often more expensive than generics and other treatment options. In the past, drug company representatives have touted new uses for existing drugs for Alzheimer’s disease, for instance, which have harmed patients.

For example, in cases involving the antipsychotic drugs Risperdal and Invega, Johnson & Johnson in 2013 agreed to pay the government $2.2 billion to settle claims that pharmaceutical representatives promoted the medications for patients with confusion or dementia, despite evidence the medications increased the risk of stoke and other problems in the elderly.

Advertise with us

Pharmaceutical companies earned more than $60 billion for the eight detailed drugs that were part of the study while generic drugs are on average 80 percent to 85 percent less expensive than branded drugs. Eight drug classes were part of the JAMA study, including medications to lower lipids, control gastroesophageal reflux disease, treat diabetes and others.

“It’s amazing how little it takes to influence how somebody thinks about something,” said George Loewenstein, one of the study’s authors and a professor of economics and psychology at Carnegie Mellon University. “The study really supports the need for more academic medical centers to adopt stronger policies.”

Pitt’s medical school was among 11 institutions where significant prescribing practice changes were found after implementation of a restrictive policy, which was enacted in early 2008, according to the study.

Restricting physician access to sales calls from the pharmaceutical industry resulted in a “pretty significant” reduction in the number of prescriptions written for products the company was pushing for various ailments, Mr. Loewenstein said.

Stanford University School of Medicine, Northwestern University Feinberg School of Medicine and the University of California, San Francisco, School of Medicine were among the other academic medical centers included in the study.

Advertise with us

Researchers analyzed 16.1 million prescriptions written between January 2006 and June 2012 by a total of 2,126 doctors. Eleven of the academic medical centers, including Pitt, had comprehensive policies regulating gifts to physicians by pharmaceutical sales staff, restricted access to clinics and medical centers, and enforcement mechanisms to assure compliance.

The board of directors of the Pharmaceutical Research and Manufacturers of America, a Washington, D.C.-based trade group, adopted its own guidelines for interactions with health care professionals in 2009. Some academic medical centers have adopted more rigid guidelines, others less restrictive, according to the JAMA study.

Direct-to-physician marketing practices are not limited to academic medical centers, according to a 2010 study that appeared in the Journal of General Internal Medicine.

“There is little evidence that physician practices outside of academic medicine have undertaken significant changes to limit acceptance of gifts,” according to the study. “A recent national survey of physicians found that 94 percent are involved in marketing relationships with pharmaceutical companies and accept some form of industry gifts or payments.”

Only a minority of academic medical centers nationwide have comprehensive policies covering physician contact with Big Pharma, Mr. Loewenstein said. But, he added, “The policies work.”

Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699.